Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
How It Works 
News - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
Lifevantage Corporation(LFVN)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for LFVN
10/02/2026: LFVN (1-star) is currently NOT-A-BUY. Pass it for now.
LifeVantage Corporation is a direct-selling company focusing on nutrigenomics, primarily known for its Nrf2-based Protandim health supplements and skincare lines. The company has a stable foundation built on scientifically supported wellness products, which provides a unique competitive niche in the fragmented direct-selling market. Its primary growth opportunity lies in international expansion and the digital transformation of its consultant network to drive efficiency. However, the company faces significant execution, regulatory, and competition risks inherent in the multi-level marketing model. It is best suited for investors who understand the risks of niche direct-selling equities and should monitor distributor productivity and regulatory updates closely.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Mixed fit | The company operates in a mature niche where growth is contingent on successful international expansion. |
| Momentum investor | Mixed fit | Momentum is highly dependent on product adoption cycles and market sentiment toward direct-selling firms. |
| Value investor | Mixed fit | The stock may offer value for those who believe the brand and science are undervalued relative to market peers. |
| Dividend investor | Weak fit | The company does not prioritize dividend payments, focusing on reinvestment and share repurchases. |
| Low-risk investor | Weak fit | High volatility inherent in small-cap direct-selling stocks makes it unsuitable for low-risk portfolios. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | High | Small-cap stocks in the MLM sector are prone to sharp price swings based on distributor recruitment trends. |
| Valuation risk | Medium | Valuations are often tied to subjective growth expectations in international markets. |
| Competition risk (Direct selling competitors) | High | The sector is saturated with established players competing for the same distributor base. |
| Business quality | Medium | The business model relies heavily on maintaining a motivated independent distributor workforce. |
| Dividend income | Low / none | Investors should not rely on this stock for consistent income generation. |
| Execution risk | Medium / high | Success depends on effective management of complex, multi-layered marketing and sales operations. |
Price Behavior
Strong Uptrend
The stock has maintained a strong upward price trend across the last three quarters.
Extreme Price Shocks
The stock has experienced exceptionally large and disruptive price movements during the period.
Analysis of Past Performance
Type Stock | Historic Profit 79.97% | Avg. Invested days 35 | Today’s Advisory PASS |
Upturn Advisory Rating  | Upturn Advisory Performance  4.0 | Stock Returns Performance  4.0 |
| Profits based on simulation | Last Close 10/02/2026 |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals
Financial Health Rating
Growth Momentum Score
Ownership
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue)
Economic Dimensions
Quantitative Style Profile
Style Classification
Quality Focused
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 78.56M USD | Price to earnings Ratio 16 | 1Y Target Price 7.5 |
Price to earnings Ratio 16 | 1Y Target Price 7.5 | ||
Volume (30-day avg) 46.0K shares | Beta 0.76 | 52 Weeks Range 3.81 - 11.62 | Updated Date 10/02/2026 |
52 Weeks Range 3.81 - 11.62 | Updated Date 10/02/2026 | ||
Dividends yield (FY) 2.94% | Basic EPS (TTM) 0.39 |
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Nutraceuticals (Protandim) | Nrf2 synergetic supplements sold globally. | This is the primary revenue engine relying on network sales. |
| Personal Care (TrueScience) | Skincare products utilizing proprietary anti-aging technology. | This serves as a complementary product line to increase average order values. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Valuation
Trailing PE 16 | Forward PE 37.45 | Enterprise Value 71.87M | Price to Sales(TTM) 0.43 |
Enterprise Value 71.87M | Price to Sales(TTM) 0.43 | ||
Enterprise Value to Revenue 0.39 | Enterprise Value to EBITDA 8.1 | Shares Outstanding 12.59M | Shares Floating 9.09M |
Shares Outstanding 12.59M | Shares Floating 9.09M | ||
Percent Insiders 12.55 | Percent Institutions 53.67 |
Upturn AI Summary
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.
About Lifevantage Corporation
Exchange NASDAQ | Headquarters Lehi, UT, United States | ||
IPO Launch date 2004-10-05 | CEO - | ||
Sector Consumer Defensive | Industry Packaged Foods | Full time employees 209 | Website https://www.lifevantage.com |
Full time employees 209 | Website https://www.lifevantage.com | ||
LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, weight management, gut health, and skin and hair care products in the United States and internationally. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 and Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; LifeVantage Daily Wellness, a dietary supplement to strengthen immune health; LifeVantage Rise AM and Reset PM System that provides the body with the right nutrients; LifeVantage D3+, a dietary supplement that provides vitamin D3 and K2, magnesium, calcium, and other trace minerals to support a balanced immune system, strong bones, and cardiovascular health; P84 System, a product activator consisting of PhytoPower 1 and PhytoPower 2 that contains probiotics, prebiotics, postbiotics, digestive enzymes, and superfood blends designed to support gut health; MindBody GLP-1 System, a dietary supplement that combines two products, MB Core and MB Enhance, which are designed to support weight management and wellness by activating GLP-1 naturally and balancing signals along the gut-brain axis; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix. It also provides anti-aging skin care products, such as liquid collagen, facial cleansers, eye cream, moisturizing cream, sunscreen, perfecting lotions, and hand creams, as well as shampoos, nourishing conditioners, and scalp serums under the TrueScience brand name. It sells its products through its website and network of independent consultants. LifeVantage Corporation is based in Lehi, Utah.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.